Viral Genetics, Inc. (OTC BB: VRAL), a drug development company developing a biological therapy for the treatment of HIV infection, today announced that Robert Siegel, MD, has joined the Company's Scientific and Medical Advisory Board. The appointment of Dr. Siegel is part of a wider Company effort to expand its research and development efforts into areas beyond HIV and AIDS.
